# Arcturus Therapeutics Holdings Inc.: Form 8-K, filed Feb 23, 2024

- Company: [Arcturus Therapeutics Holdings Inc.](/companies/arct.md) (CIK 1768224)
- Form: 8-K
- Filed: 2024-02-23
- Accepted by EDGAR: Feb 23, 2024, 16:05 ET
- Period: 2024-02-20
- Accession: 0001193805-24-000264
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1768224/000119380524000264/e619292_8k-arct.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1768224/000119380524000264/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1768224/000119380524000264/e619292_8k-arct.htm

Filed Feb 23, 2024.
Source: SEC EDGAR, the filing index for accession 0001193805-24-000264. Last ingested by Listed: Nov 14, 2026, 14:45 ET. No prices; not investment advice.
